INSOMNIA is the #16 most commonly reported adverse reaction for ANASTROZOLE, manufactured by ANI Pharmaceuticals, Inc.. There are 1,262 FDA adverse event reports linking ANASTROZOLE to INSOMNIA. This represents approximately 1.6% of all 80,386 adverse event reports for this drug.
Patients taking ANASTROZOLE who experience insomnia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
INSOMNIA1,262 of 80,386 reports
INSOMNIA is a less commonly reported adverse event for ANASTROZOLE, but still significant enough to appear in the safety profile.
Other Side Effects of ANASTROZOLE
In addition to insomnia, the following adverse reactions have been reported for ANASTROZOLE:
INSOMNIA has been reported as an adverse event in 1,262 FDA reports for ANASTROZOLE. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is INSOMNIA with ANASTROZOLE?
INSOMNIA accounts for approximately 1.6% of all adverse event reports for ANASTROZOLE, making it a notable side effect.
What should I do if I experience INSOMNIA while taking ANASTROZOLE?
If you experience insomnia while taking ANASTROZOLE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.